TOP > Partnering Opportunities

Y's Therapeutics focuses on the development of preclinical and early-stage clinical projects, and pursues research collaborations and in-licensing opportunities from academic institutions and biotech companies. We intend to seek collaborative relationships, including out-licensing of product rights and creation of joint ventures, for late-stage development, manufacturing and commercialization.

We are currently looking for out-licensing opportunities & co-development partners for the following projects.

YSPSL

Recombinant P-selectin glycoprotein ligand-Ig (rPSGL-Ig) Selectin Antagonist R&D Stage : Phase II Click here for details

YSCMA		Anti-CD26 Humanized Monoclonal Antibody(IgG1) R&D Stage : IND Click here for details

For more information, please contact

<Japan>
Yoshio Hioki
Y's Therapeutics Co., Ltd.
Phone : +81-3-5784-2762
bizdev@ysthera.com

<U.S.A.>
Scott McNinch
Y's Therapeutics, Inc.
Phone : +1-650-777-7001
bizdev@ysthera.com

Top  |  Site Map  |  Access Map  |  Privacy Policy  |  Terms of Use